Literature DB >> 10773417

Temporal profile of release of interleukin-1beta in neurotrauma.

K Fassbender1, S Schneider, T Bertsch, D Schlueter, M Fatar, A Ragoschke, S Kühl, U Kischka, M Hennerici.   

Abstract

Timing and extent of trauma-induced release of interleukin-1beta (IL-1beta) in extracellular fluid of the CNS were analyzed. In brain tissue perfusates obtained by in vivo microdialysis a marked release of IL-1beta was unexpectedly detected within less than 60 min. At such an early stage of neurotrauma, mRNA expression of IL-1beta was detected whereas immunoreactivity for the IL-1beta protein was negative. Concentrations of extracellularly secreted IL-1beta protein gradually increased, peaked at day 2 and decreased thereafter. Drugs acting on mononuclear phagocytes significantly modulated IL-1beta secretion. This so far unrecognized acuity of IL-1beta release demonstrated here, may represent a precondition for the orchestrating role of this mediator in the cascade of inflammatory host response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10773417     DOI: 10.1016/s0304-3940(00)00977-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  33 in total

Review 1.  [The relevance of the inflammatory response in the injured brain].

Authors:  O I Schmidt; I Leinhase; E Hasenboehler; S J Morgan; P F Stahel
Journal:  Orthopade       Date:  2007-03       Impact factor: 1.087

Review 2.  What has inflammation to do with traumatic brain injury?

Authors:  David Cederberg; Peter Siesjö
Journal:  Childs Nerv Syst       Date:  2009-11-26       Impact factor: 1.475

3.  Minozac treatment prevents increased seizure susceptibility in a mouse "two-hit" model of closed skull traumatic brain injury and electroconvulsive shock-induced seizures.

Authors:  MaryAnn Chrzaszcz; Charu Venkatesan; Tina Dragisic; D Martin Watterson; Mark S Wainwright
Journal:  J Neurotrauma       Date:  2010-07       Impact factor: 5.269

4.  Acute neuroimmune modulation attenuates the development of anxiety-like freezing behavior in an animal model of traumatic brain injury.

Authors:  Krista M Rodgers; Florencia M Bercum; Danielle L McCallum; Jerry W Rudy; Lauren C Frey; Kirk W Johnson; Linda R Watkins; Daniel S Barth
Journal:  J Neurotrauma       Date:  2012-04-26       Impact factor: 5.269

5.  Elevated leptin expression in rat model of traumatic spinal cord injury and femoral fracture.

Authors:  Lei Wang; Xingguo Tang; Hongxi Zhang; Jishan Yuan; Hua Ding; Yongzhong Wei
Journal:  J Spinal Cord Med       Date:  2011       Impact factor: 1.985

6.  Immune activation promotes depression 1 month after diffuse brain injury: a role for primed microglia.

Authors:  Ashley M Fenn; John C Gensel; Yan Huang; Phillip G Popovich; Jonathan Lifshitz; Jonathan P Godbout
Journal:  Biol Psychiatry       Date:  2013-10-25       Impact factor: 13.382

7.  Systemic inflammation exacerbates behavioral and histopathological consequences of isolated traumatic brain injury in rats.

Authors:  Akira Utagawa; Jessie S Truettner; W Dalton Dietrich; Helen M Bramlett
Journal:  Exp Neurol       Date:  2008-02-20       Impact factor: 5.330

8.  Interleukin 1beta and interleukin 6 relationship with paediatric head trauma severity and outcome.

Authors:  Antonio Chiaretti; Orazio Genovese; Luigi Aloe; Alessia Antonelli; Marco Piastra; Giancarlo Polidori; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2004-09-29       Impact factor: 1.475

9.  Simvastatin attenuates microglial cells and astrocyte activation and decreases interleukin-1beta level after traumatic brain injury.

Authors:  Bo Li; Asim Mahmood; Dunyue Lu; Hongtao Wu; Ye Xiong; Changsheng Qu; Michael Chopp
Journal:  Neurosurgery       Date:  2009-07       Impact factor: 4.654

10.  Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury.

Authors:  Juan Pablo de Rivero Vaccari; George Lotocki; Ofelia F Alonso; Helen M Bramlett; W Dalton Dietrich; Robert W Keane
Journal:  J Cereb Blood Flow Metab       Date:  2009-04-29       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.